Andere Sprachen Telesis Bio, Inc.

Aktien

A3CSHS

US1920031010

TBIO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
0.3213 ^USD	-0.68%		-12.57%	-19.47%

18.04.	Telesis Bio, Inc. gibt die Ernennung von Eric Esser zum Mitglied des Vorstands bekannt	CI
18.04.	Telesis Bio Inc. kündigt strategische Fokussierung auf die bahnbrechende Gibson Sola Plattform für enzymatische DNA-Synthese (EDS) und BioXp mRNA-Lösungen an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership	18.04.
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors	18.04.
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	18.04.
Telesis Bio, Inc. Announces Chief Executive Officer Changes	18.04.
Telesis Bio : Shareholder Meeting - Form 8-K	08.04.
Telesis Bio: Q4 Earnings Snapshot	28.03.
Earnings Flash (TBIO) TELESIS BIO Reports Q4 Revenue $7M	28.03.
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results	28.03.
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.03.
Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023	28.03.
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA	27.02.
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	26.02.
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	26.02.
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	26.02.
Thinking about buying stock in Telesis Bio, Sellas Life Sciences, Mitek Systems, Monopar Therapeutics, or Inpixon?	23.02.
Earnings Flash (TBIO) TELESIS BIO Posts Q3 Revenue $5.6M, vs. Street Est of $7.4M	13.11.
Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Telesis Bio Reports Third Quarter 2023 Financial Results	13.11.
Telesis Bio Reports Third Quarter 2023 Financial Results	13.11.
Telesis Bio, Inc. Provides Earnings Guidance for 2023	13.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Telesis Bio, Inc.

Aktien

A3CSHS

US1920031010

TBIO

Andere Sprachen

Filter